期刊文献+

HBV-YMDD变异患者与中医虚实辨证关系初探 被引量:11

Study on the relation of deficiency syndrome and sufficiency syndrome of TCM in patients with HBV-YMDD mutation
下载PDF
导出
摘要 目的 :初步探讨服用拉米夫定后HBV -YMDD变异患者中医辨证虚证、实证之间的关系。方法 :对服用拉米夫定半年以上的乙型慢性病毒性肝炎患者采用联合基因集团上海博华基因技术有限公司出品的迈科锐乙型肝炎病毒突变检测基因芯片 ,进行HBV -YMDD变异检测。出现HBV -YMDD者 ,根据中医基础理论 ,将其分为实证、虚证 ,来探讨HBV -YMDD变异患者中医虚、实辨证的关系。结果 :HBV -YMDD变异患者中实证变异率(38/ 4 8)明显高于虚证 (10 / 4 8) ,具有统计学意义。结论 :HBV -YMDD变异与虚、实辨证之间具有相关性。 Objective:To study on the relation of deficiency syndrome and sufficiency syndrome of TCM in patients with HBV-YMDD mutation.Methods:After the treatment of Lamivudine for half a year,the blood of patients were tested by Gene Chip.Patients with HBV-YMDD mutation were differentiated into deficiency syndrome and sufficiency syndrome in theory of TCM.Then we study the relation of deficiency syndrome and sufficiency syndrome of TCM in patients with HBV-YMDD mutation.Result:The rate of deficiency syndrome(38/48) is more than the sufficiency syndrome′s(10/48),and there is signification in statistics.Conclusion:It seems that there is some relationship in deficiency syndrome,sufficiency syndrome and HBV-YMDD mutation.
出处 《辽宁中医杂志》 CAS 2004年第9期731-732,共2页 Liaoning Journal of Traditional Chinese Medicine
关键词 HBV—YMDD变异 中医辨证 虚证 实证 HBV-YMDD mutation syndrome differentiations of TCM deficiency syndrome sufficiency syndrome
  • 相关文献

参考文献6

二级参考文献7

  • 1戴志澄 祁国明 等.乙肝病毒性肝炎的流行特征,中国病毒性肝炎血清流行病学调查1992-1995[M].北京:科学技术文献出版社,1997.39-59.
  • 2Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
  • 3Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
  • 4Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
  • 5Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
  • 6拉米夫定临床应用专家指导小组.2000年拉米夫定临床应用指导意见[J].中华肝脏病杂志,2000,8(4):249-250. 被引量:114
  • 7拉米夫定临床应用专家指导小组.2001年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2002,10(2):157-158. 被引量:71

共引文献14479

同被引文献229

引证文献11

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部